{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:59:44Z","timestamp":1794380384916,"version":"4.9.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neurol.2023.02.070","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T12:51:23Z","timestamp":1691067083000},"page":"12-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["PSP-Richardson syndrome mimics: An overview and pragmatic approach"],"prefix":"10.1016","volume":"180","author":[{"given":"J.","family":"Necp\u00e1l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Borsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Jele\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2023.02.070_bib0540","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.04.014","article-title":"Progressive supranuclear palsy: advances in diagnosis and management","volume":"73","author":"Coughlin","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0545","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","article-title":"Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies","volume":"17","author":"Stamelou","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0550","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0555","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2023.02.070_bib0560","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0565","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1007\/s10072-021-05601-8","article-title":"\u201cParkinson's disease\u201d on the way to progressive supranuclear palsy: a review on PSP-parkinsonism","volume":"42","author":"Necp\u00e1l","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2023.02.070_bib0570","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ane.12546","article-title":"Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants","volume":"134","author":"Lopez","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2023.02.070_bib0575","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/mds.21698","article-title":"Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy","volume":"22","author":"Williams","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0580","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14802\/jmd.15060","article-title":"Clinical approach to progressive supranuclear palsy","volume":"9","author":"Ling","year":"2016","journal-title":"J Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0585","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0590","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mdc3.12011","article-title":"\u201cRapidly\u201d progressive supranuclear palsy","volume":"1","author":"Armstrong","year":"2014","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.neurol.2023.02.070_bib0595","doi-asserted-by":"crossref","first-page":"18","DOI":"10.15406\/jnsk.2022.12.00491","article-title":"Unusual progressive supranuclear palsy: a case report","volume":"12","author":"Ahmed","year":"2022","journal-title":"J Neurol Stroke"},{"key":"10.1016\/j.neurol.2023.02.070_bib0600","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/mds.25509","article-title":"Atypical\u201d atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide","volume":"28","author":"Stamelou","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0605","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2016.12.006","article-title":"\u201cAtypical\u201d atypical parkinsonism: critical appraisal of a cohort","volume":"37","author":"Hirschbichler","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0610","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fneur.2017.00429","article-title":"Clinical approach to supranuclear brainstem saccadic gaze palsies","volume":"23","author":"Lloyd-Smith Sequeira","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0615","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JPD-202302","article-title":"Genetics of progressive supranuclear palsy: a review","volume":"11","author":"Wen","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.neurol.2023.02.070_bib0620","doi-asserted-by":"crossref","first-page":"804385","DOI":"10.3389\/fnagi.2022.804385","article-title":"Differential diagnosis of rare subtypes of progressive supranuclear palsy and PSP-like syndromes-infrequent manifestations of the most common form of atypical parkinsonism","volume":"14","author":"Krzosek","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurol.2023.02.070_bib0625","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/cjn.2018.367","article-title":"Progressive supranuclear palsy-like syndrome from possible cerebral amyloid angiopathy","volume":"46","author":"Shetty","year":"2019","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neurol.2023.02.070_bib0630","doi-asserted-by":"crossref","first-page":"599384","DOI":"10.3389\/fneur.2020.599384","article-title":"Tauopathy and movement disorders-unveiling the chameleons and mimics","volume":"11","author":"Ganguly","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0635","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/awab017","article-title":"Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy","volume":"144","author":"Miki","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2023.02.070_bib0640","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2013.03.008","article-title":"Progressive supranuclear palsy phenotype mimicking synucleinopathies","volume":"329","author":"Men\u0161\u00edkov\u00e1","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2023.02.070_bib0645","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-150203","article-title":"Progressive supranuclear palsy syndrome and semantic dementia in neuropathologically proven Lewy body disease: a report of two cases","volume":"47","author":"Lagarde","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2023.02.070_bib0650","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0655","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/mds.10264","article-title":"Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein","volume":"17","author":"Morales","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0660","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/JAD-2002-4506","article-title":"Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin station","volume":"4","author":"S\u00e1nchez","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2023.02.070_bib0665","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mdc3.12406","article-title":"Progressive supranuclear palsy-like phenotype in a GBA E326K mutation carrier","volume":"4","author":"Picillo","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.neurol.2023.02.070_bib0670","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/mds.23221","article-title":"Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations","volume":"25","author":"Pais\u00e1n-Ruiz","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0675","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","article-title":"Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism","volume":"34","author":"Quadri","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2023.02.070_bib0680","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archneur.1975.00490440058009","article-title":"Hereditary mental depression and Parkinsonism with taurine deficiency","volume":"32","author":"Perry","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.20060","article-title":"Concept of a new disease and clinical diagnostic criteria","volume":"14","author":"Tsuboi","year":"2021","journal-title":"J Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0690","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","article-title":"Establishing diagnostic criteria for Perry syndrome","volume":"89","author":"Mishima","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2023.02.070_bib0695","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamaneurol.2013.5100","article-title":"DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes","volume":"77","author":"Caroppo","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0700","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.parkreldis.2017.06.004","article-title":"DCTN1-related neurodegeneration: Perry syndrome and beyond","volume":"41","author":"Konno","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0705","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1212\/01.wnl.0000187068.92184.63","article-title":"Comparison of family histories in FTLD subtypes and related tauopathies","volume":"65","author":"Goldman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.02.070_bib0710","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/ana.10572","article-title":"Epidemiology and genetics of frontotemporal dementia\/Pick's disease","volume":"5","author":"Bird","year":"2003","journal-title":"Ann Neurol Suppl"},{"key":"10.1016\/j.neurol.2023.02.070_bib0715","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1212\/WNL.0000000000200860","article-title":"Differences in motor features of C9orf72, MAPT, or GRN variant carriers with familial frontotemporal lobar degeneration","volume":"99","author":"Tipton","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.02.070_bib0720","doi-asserted-by":"crossref","first-page":"e82879","DOI":"10.1371\/journal.pone.0082879","article-title":"Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders","volume":"8","author":"Zech","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2023.02.070_bib0725","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00702-019-02058-0","article-title":"Late-onset Niemann-Pick disease type C overlapping with frontotemporal dementia syndromes: a case report","volume":"126","author":"Bal\u00e1zs","year":"2019","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.neurol.2023.02.070_bib0730","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1971400915621324","article-title":"Characteristic brain MRI findings in ataxia-neuropathy spectrum related to POLG station","volume":"29","author":"Henao","year":"2016","journal-title":"Neuroradiol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0735","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.55.6.800","article-title":"Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese","volume":"55","author":"Gwinn-Hardy","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.02.070_bib0740","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.parkreldis.2006.04.009","article-title":"The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment","volume":"13","author":"Lin","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0745","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40673-021-00134-4","article-title":"Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction","volume":"8","author":"Norioka","year":"2021","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.neurol.2023.02.070_bib0750","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mds.27812","article-title":"Parkinsonism and spastic paraplegia type 7: expanding the spectrum of mitochondrial parkinsonism","volume":"34","author":"De la Casa-Fages","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0755","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJM199712183372508","article-title":"Transmissible spongiform encephalopathies","volume":"337","author":"Haywood","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2023.02.070_bib0760","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1468-1331.2004.00780.x","article-title":"Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy","volume":"34","author":"Joseph","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0765","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2006.11.010","article-title":"Supranuclear vertical gaze abnormalities in sporadic Creutzfeldt-Jakob disease","volume":"253","author":"Prasad","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2023.02.070_bib0770","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000358483","article-title":"Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like creutzfeldt-Jakob disease","volume":"6","author":"Rissanen","year":"2014","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0775","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00415-012-6752-7","article-title":"MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy","volume":"260","author":"Petrovic","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0780","first-page":"125","article-title":"Creutzfeldt-Jakob disease with slow progression. A mimickry of progressive supranuclear palsy","volume":"2","author":"Huber","year":"2007","journal-title":"Bull Soc Sci Med Grand Duche Luxemb"},{"key":"10.1016\/j.neurol.2023.02.070_bib0785","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40734-019-0082-1","article-title":"A case of Gerstmann-Straussler-Scheinker (GSS) disease with supranuclear gaze palsy","volume":"6","author":"Ufkes","year":"2019","journal-title":"J Clin Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0790","first-page":"93","article-title":"Gerstmann-Str\u00e4ussler-Scheinker disease presenting with atypical parkinsonism, but typical magnetic resonance imaging findings of Prion disease","volume":"6","author":"Ribosa-Nogu\u00e9","year":"2015","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.neurol.2023.02.070_bib0795","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/WNL.37.4.570","article-title":"Progressive supranuclear palsy and a multi-infarct state","volume":"37","author":"Dubinsky","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.02.070_bib0800","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-7091-6641-3_15","article-title":"Vascular progressive supranuclear palsy","volume":"42","author":"Winikates","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neurol.2023.02.070_bib0805","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archneur.59.10.1597","article-title":"A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy","volume":"59","author":"Josephs","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0810","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.043","article-title":"Epileptic seizure as a precipitating factor of vascular progressive supranuclear palsy: a case report","volume":"23","author":"Lanza","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2023.02.070_bib0815","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/mds.20407","article-title":"Progressive supranuclear palsy-like phenotype associated with bilateral hypoxic-ischemic striopallidal lesions","volume":"20","author":"Kim","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0820","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mds.10347","article-title":"Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome","volume":"18","author":"Weeks","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0825","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ncn3.12172","article-title":"Progressive supranuclear palsy with cerebral amyloid angiopathy","volume":"6","author":"Hatano","year":"2018","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.neurol.2023.02.070_bib0830","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1353-8020(02)00146-3","article-title":"Progressive supranuclear palsy phenotype secondary to CADASIL","volume":"9","author":"Van Gerpen","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0835","series-title":"Case studies in Movement Disorders \u2013 Common and uncommon presentations","first-page":"31","article-title":"PSP Look-Alike due to CADASIL","author":"Erro","year":"2017"},{"key":"10.1016\/j.neurol.2023.02.070_bib0840","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12916-017-0778-8","article-title":"Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects","volume":"15","author":"Di Donato","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.neurol.2023.02.070_bib0845","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s42466-020-0053-x","article-title":"Antibody-related movement disorders\u00a0\u2013\u00a0a comprehensive review of phenotype-autoantibody correlations and a guide to testing","volume":"2","author":"G\u00f6vert","year":"2020","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.neurol.2023.02.070_bib0850","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2023.02.070_bib0855","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneurol.2011.56","article-title":"Narcolepsy, REM sleep behavior disorder, and supranuclear gaze palsy associated with Ma1 and Ma2 antibodies and tonsillar carcinoma","volume":"68","author":"Adams","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0860","doi-asserted-by":"crossref","first-page":"577345","DOI":"10.1016\/j.jneuroim.2020.577345","article-title":"Anti-RI antibody associated progressive supranuclear palsy like presentation in a patient with breast carcinoma","volume":"347","author":"Takkar","year":"2020","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0865","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jocn.2016.02.032","article-title":"Paraneoplastic syndrome mimicking progressive supranuclear palsy","volume":"32","author":"Dash","year":"2016","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.neurol.2023.02.070_bib0870","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/tohm.65","article-title":"Moaning phenomenon and rapidly progressive dementia in anti-LGI-1 associated progressive supranuclear palsy syndrome","volume":"10","author":"Hierro","year":"2020","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.neurol.2023.02.070_bib0875","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4103\/aian.AIAN_538_20","article-title":"Redeemable \u201cProgressive Supranuclear Palsy\u201d like paraneoplastic presentation in carcinoma breast","volume":"24","author":"Cherian","year":"2021","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0880","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/WNL.35.3.446-a","article-title":"Progressive supranuclear palsy: paraneoplastic effect of bronchial carcinoma","volume":"35","author":"Jankovic","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.02.070_bib0885","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.parkreldis.2004.09.003","article-title":"Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma","volume":"11","author":"Tan","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0890","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0895","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0900","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2023.02.070_bib0905","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.02.070_bib0910","doi-asserted-by":"crossref","first-page":"753856","DOI":"10.3389\/fimmu.2021.753856","article-title":"Ocular motor abnormalities in anti-IgLON5 disease","volume":"12","author":"Macher","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0915","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/ene.14634","article-title":"Altered ioflupane single-photon emission computed tomography in anti-IgLON5 disease: a new case mimicking probable progressive supranuclear palsy and review of the literature","volume":"28","author":"Gonz\u00e1lez-\u00c1vila","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0920","doi-asserted-by":"crossref","first-page":"40","DOI":"10.29245\/2572.942X\/2020\/3.1269","article-title":"Anti-Iglon5 syndrome: what we know so far? A non-systematic review","volume":"5","author":"Silva","year":"2020","journal-title":"J Neurol Neuromed"},{"key":"10.1016\/j.neurol.2023.02.070_bib0925","doi-asserted-by":"crossref","first-page":"e962","DOI":"10.1212\/NXI.0000000000000962","article-title":"Anti-IgLON5 disease: a new bulbar-onset motor neuron mimic syndrome","volume":"8","author":"Werner","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2023.02.070_bib0930","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/ane.13207","article-title":"Response to immunotherapy in anti-IgLON5 disease: a systematic review","volume":"141","author":"Cabezudo-Garc\u00eda","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2023.02.070_bib0935","first-page":"988","article-title":"L\u2019atteinte neurologique dans la maladie de Whipple [Neurological manifestations of Whipple disease]","volume":"158","author":"Vital Durand","year":"2002","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib0940","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/mds.27419","article-title":"Systematic review of movement disorders and oculomotor abnormalities in Whipple's disease","volume":"33","author":"Bally","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0945","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/jnnp.66.4.532","article-title":"Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording","volume":"66","author":"Averbuch-Heller","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2023.02.070_bib0950","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp.45.1.86","article-title":"Vertical supranuclear gaze palsy with secondary syphilis","volume":"45","author":"Page","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2023.02.070_bib0955","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/1531-8257(200007)15:4<730::AID-MDS1020>3.0.CO;2-O","article-title":"Neurosyphilis presenting as progressive supranuclear palsy","volume":"15","author":"Murialdo","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib0960","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/00023210-200216100-00002","article-title":"HIV-related movement disorders: epidemiology, pathogenesis and management","volume":"16","author":"Cardoso","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurol.2023.02.070_bib0965","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10072-011-0875-y","article-title":"Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection","volume":"33","author":"Jang","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2023.02.070_bib0970","doi-asserted-by":"crossref","first-page":"e227119","DOI":"10.1136\/bcr-2018-227119","article-title":"Chronic meningoencephalitis with mixed pathology mimics progressive supranuclear palsy","volume":"11","author":"Dale","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.neurol.2023.02.070_bib0975","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/NRL.0b013e31821735ad","article-title":"Rheumatoid meningitis mimicking progressive supranuclear palsy","volume":"17","author":"Aguilar-Amat","year":"2011","journal-title":"Neurologist"},{"key":"10.1016\/j.neurol.2023.02.070_bib0980","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4103\/0028-3886.82763","article-title":"Progressive supranuclear palsy like syndrome: neurocysticercosis an unusual cause","volume":"59","author":"Sharma","year":"2011","journal-title":"Neurol India"},{"key":"10.1016\/j.neurol.2023.02.070_bib0985","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1212\/01.WNL.0000115170.40838.9B","article-title":"Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysma","volume":"62","author":"Mokri","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.02.070_bib0990","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.157","article-title":"Progressive supranuclear palsy-like syndrome after aortic aneurysm repair: a case series","author":"Nandipati","year":"2013","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.neurol.2023.02.070_bib0995","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.21201","article-title":"Saccadic palsy after cardiac surgery: characteristics and pathogenesis","volume":"63","author":"Solomon","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib1000","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/nyas.12666","article-title":"Saccadic palsy following cardiac surgery: a review and new hypothesis","volume":"1343","author":"Eggers","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2023.02.070_bib1005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/CPJ.0000000000000708","article-title":"PSP-like syndrome after aortic surgery in adults (Mokri syndrome)","volume":"10","author":"Tisel","year":"2020","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.neurol.2023.02.070_bib1010","unstructured":"Kim H.J., Lee J.H. Reversible progressive supranuclear palsy-mimic induced by risperidone [abstract]. Mov Disord 2017;32(suppl 2) https:\/\/www.mdsabstracts.org\/abstract\/reversible-progressive-supranuclear-palsy-mimic-induced-by-risperidone\/. Accessed August 1, 2023."},{"key":"10.1016\/j.neurol.2023.02.070_bib1015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/AOMD.AOMD_12_19","article-title":"Reversible drug-induced progressive supranuclear palsy-like presentation: a report of three cases","volume":"2","author":"Rath","year":"2019","journal-title":"Ann Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib1020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mds.10692","article-title":"Progressive supranuclear palsy syndrome induced by clebopride","volume":"19","author":"Campdelacreu","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib1025","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1590\/S0004-282X2009000500027","article-title":"Progressive supranuclear palsy-like syndrome induced by amiodarone and flunarizine","volume":"67","author":"Mattos","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.neurol.2023.02.070_bib1030","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1212\/WNL.0000000000000748","article-title":"Intraventricular tumor presenting as progressive supranuclear palsy-like phenotype","volume":"83","author":"Morelli","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.02.070_bib1035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/mds.870040309","article-title":"Cerebral sarcoidosis presenting as supranuclear gaze palsy with hypokinetic rigid syndrome","volume":"4","author":"Schlegel","year":"1989","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.02.070_bib1040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/147323000703500119","article-title":"Progressive supranuclear palsy-like parkinsonism resulting from occupational exposure to lead sulphate batteries","volume":"35","author":"Sanz","year":"2007","journal-title":"J Int Med Res"},{"key":"10.1016\/j.neurol.2023.02.070_bib1045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3988\/jcn.2007.3.1.57","article-title":"Striopallidodentate calcification and progressive supranuclear palsy-like phenotype in a patient with idiopathic hypoparathyroidism","volume":"3","author":"Kim","year":"2007","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib1050","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/0366-6999.176067","article-title":"Idiopathic basal ganglia calcification presented with progressive supranuclear palsy-like features","volume":"129","author":"Li","year":"2016","journal-title":"Chin Med J"},{"key":"10.1016\/j.neurol.2023.02.070_bib1055","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/ene.14322","article-title":"Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features","volume":"27","author":"Ohara","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib1060","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00415-012-6745-6","article-title":"Normal pressure hydrocephalus or progressive supranuclear palsy? A clinicopathological case series","volume":"260","author":"Magdalinou","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2023.02.070_bib1065","first-page":"1","article-title":"Idiopathic normal pressure hydrocephalus-like MRI features in patients with progressive supranuclear palsy: a comparative case-control study","author":"Onder","year":"2022","journal-title":"Neurol Res"},{"key":"10.1016\/j.neurol.2023.02.070_bib1070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2054-7072-1-2","article-title":"Hydrocephalic Parkinsonism: lessons from normal pressure hydrocephalus mimics","volume":"1","author":"Starr","year":"2014","journal-title":"J Clin Mov Disord"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723009803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723009803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:48:09Z","timestamp":1758520089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723009803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":107,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0035378723009803"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2023.02.070","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSP-Richardson syndrome mimics: An overview and pragmatic approach","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2023.02.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}